Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam
· Delayed Price · Currency is VND 69,200
0.00 (0.00%)
At close: Mar 6, 2026
Ha Tay Pharmaceutical JSC Revenue
In the year 2025, Ha Tay Pharmaceutical JSC had annual revenue of 2.40T VND with 15.13% growth. Ha Tay Pharmaceutical JSC had revenue of 692.88B in the quarter ending December 31, 2025, with 27.74% growth.
Revenue
2,402.04B
Revenue Growth
+15.13%
P/S Ratio
2.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
6,267.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2,402.04B | 315.69B | 15.13% |
| Dec 31, 2024 | 2,086.35B | 87.05B | 4.35% |
| Jan 1, 2024 | 1,999.30B | 161.91B | 8.81% |
| Dec 31, 2022 | 1,837.39B | 228.03B | 14.17% |
| Dec 31, 2021 | 1,609.36B | -397.11B | -19.79% |
| Jan 1, 2021 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1,865.23B |
| Imexpharm | 2,441.09B |
| Cuu Long Pharmaceutical JSC | 1,321.59B |
| Traphaco JSC | 2,651.81B |
| DHG Pharmaceutical JSC | 4,983.17B |
| Domesco Medical Import - Export Joint-Stock | 2,078.82B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| OPC Pharmaceutical JSC | 1,122.99B |